WHO minimum public health data set on prison health

Slides:



Advertisements
Similar presentations
Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.
Advertisements

Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups funded by the European Commissions Directorate General for Health.
Workshop IV: Provision of Health Care The Impact of International Standards and Guidelines on prisoner health in Eastern and Central Europe Antalya, Turkey.
Meeting the Health Needs of Offenders Dave Spurgeon Research & Development Manager, Nacro Transforming Rehabilitation Dave Spurgeon, Research & DVE.
EMCDDA Conference Lisbon 6-8 May 2009 Treatment and Harm Reduction in Prison and Continuity of Care Caren Weilandt WIAD (Scientific Institute of the German.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Model regulations on demand reduction in Europe Bylaw on drug demand reduction.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
HIV and drug prevention in Estonia Harm reduction services
Treatment of drug addiction in prisons
Estimation of the Prevalence of Problem Drug Use in Lithuania Dr Gordon Hay Centre for Drug Misuse Research University of Glasgow, United Kingdom.
Health Promotion Networks. Copenhagen, Denmark. 16 October The Health in Prisons Programme HIPP – WHO/Europe’s Network on Prison & Health Stefan.
Results from the Spanish experience: A comprehensive approach to HIV and HCV in prisons MERCEDES GALLIZO LLAMAS Secretary-General of Spanish Prison Administration.
Annual report 2010: the state of the drugs problem in Europe.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
Harm Reduction International
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
19 June 2007 Prison & Health Expert Meeting Paris Drugs and prisons DG SANCO C4 N. GRENIER.
Health in Prisons Project Oslo, 24 November 2009 Lars Moller Regional Adviser a.i. World Health Organization Regional Office for Europe Health in Prisons.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
2008 International AIDS Conference UNGASS reporting Matthew Warner-Smith Monitoring and Evaluation Division UNAIDS 2008 International AIDS Conference Satellite.
Health in Prisons Project 7 th Meeting Prison Health Expert Group - Vilnius, Lithuania, 9 February 2009 WHO Health in Prisons Project 7th meeting Prison.
PREVENTION OF INFECTIOUS DISEASES IN PRISONS Recent Experience from Portugal Henrique Barros Ministério da Saúde.
Health in Prisons – A WHO guide to the essentials in prison health NDPHS meeting Paris, June 2007 Dr Lars Moller, PhD World Health Organization.
Preventing Alcohol Exposure During Pregnancy in the European Region – Evidence, Case Stories and Challenges Dr Lisa Schölin Consultant on Alcohol, Illicit.
Communicable Diseases in Prisons, Threats and Opportunities
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Maldives Last updated: September 2016.
Bhutan Last updated: September 2016.
AN OVERVIEW OF NON COMMUNICABLE DISEASES SWAZILAND
Mongolia Last updated: April 2016.
Review in slides Malaysia.
How does teamwork improve value. Dr Nils E
Prisons and TB in Europe
Dr Lars Moller Project Manager World Health Organization
Pakistan Last updated: July 2015.
Myanmar Last Update: September 2016.
Addressing Drug Use Together Through a Health Based Approach:
Community Action on Harm Reduction (CAHR) Programme
Harm Reduction 24/7: The supply of harm reduction materials via vending machines for drug users in North Rhine-Westphalia, Germany. Prof. Dr. Daniel.
Dr Lars Moller, PhD Project Manager Health in Prisons Project
Access Equity in Prisons in Africa A CALL FOR ACTION
United Nations Statistics Division DESA, New York
People who inject drugs
Presented by Richard Laing
United Nations Statistics Division DESA, New York
More information is a must
Comparison of data from WBE with other sources
WHO World Health Organization
Wellington 16 the April 2014, Rehabilitation International
Knowledge gaps in formulating TB Control Policies for Prisons
WHO World Health Organization
Lívia Vasas, PhD 2018 WHO Lívia Vasas, PhD 2018.
Prison health in the WHO European Region
WHO World Health Organization
Bhutan Last updated: July 2018.
Alcohol consumption and harm in the WHO European Region
Skopje, 21 November 2017, General Population Survey results– launch
Ingredients of a Sustainable healthcare SYSTEM– the Cayman islands experience Lizzette Yearwood.
Presentation transcript:

WHO minimum public health data set on prison health Dr Lars Moller Dr Lisa Schölin Ms Julie Brummer WHO Consultant, Alcohol and Illicit Drugs Division of Noncommunicable Diseases and Life-Course

Outline The WHO Minimum public health dataset for prison health Preliminary findings – key data on drugs Next steps

Background Risk factors for ill health are higher in the prison population compared to the general population. Most diseases have a higher prevalence than in the general population There are significant differences between the health systems in prison and in the civilian system.

Minimum public health dataset Lack of comprehensive, consistent and reliable public health data on prison populations and their health needs across the WHO European Region WHO European Region the only region with a prison health programme The minimum public health dataset for prison health sets out to obtain national data on key areas of prison health Data collection commenced October 2016

Indicator set – 7 domains Population demographics (7 indicators) E.g. total number of prisoners, number of female prisoners Prison health systems (21 indicators) E.g. government ministry responsible for prison health, health workforce statistics Risk factors for diseases (10 indicators) E.g. Risk factor prevalence (smoking, obesity, drug and alcohol use), testing protocols Disease screening (24 indicators) E.g. testing protocols, % tested and number of cases (E.g. HIV, Hep B & C, TB), availability of mental health disorder screening Prevention of communicable and non-communicable diseases (14 indicators) E.g. availability of disease prevention programmes such as needle exchange, availability of drug-free units Treatment of communicable and non-communicable diseases (7 indicators) E.g. numbers in treatment for opioid addiction, HIV and Hep C, availability of mental health support Mortality data (4 indicators) E.g. total number of deaths, number of <18 deaths, number of deaths by suicide The database will comprise approximately 85 indicators of prison health

Project funding and partners Project funding is provided by the Finnish Government Survey developed with assistance of: WHO/Europe Health In Prisons Programme (HIPP) HIPP Steering Group (Public Health England/WHO Collaborating Centre, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), United Nations Office on Drugs and Crime (UNODC), AIDS Foundation East-West (AFEW), and representatives from Switzerland, Netherlands, Spain and Slovenia) European Centre for Disease Prevention and Control (ECDC) Council of Europe European Commission Collaboration regarding indicator set design and data collection to avoid overlap and ensure consistency in indicator definitions and key figures

Preliminary results

Participating Member States 41 Member States (MS) have submitted data    

Screening

Mandatory testing* *For all or parts of prison population

Data for prevalence of drug use 7 (19%) of MS have data on number of prisoners screened for illicit drug use 6 (16%) MS have data on current injecting drug use 8 (22%) have data on ever injecting drug use The majority of member states are lacking data on prevalence of drug use, as well as number of prisoners screened

Availability of infectious diseases data *missing data not included

Healthcare services

Harm reduction Needle/syringe exchange programs for injecting drug users available in 7 (19%) of MS Disinfectants for syringes, razors, tattoo equipment available in 15 (41%) of MS

Prevention Condoms available in 78% of MS Free of charge in 86% of these MS Lubricants available in 35% of MS Free of charge in 92% of these MS National guidelines on prevention of post-release drug-related death exist in 43% of MS

Treatment for HIV and Hep C 62% of MS have data on number of prisoners under antiretroviral treatment 33% of MS have data on number of prisoners under antiviral treatment for Hep C

Availability of drugs treatment

Next steps

Data All data will be made available on the Global Health Observatory (11 December 2017) Country profiles for each participating Member State, including key indicators (December 2017)

Continued work The submitted data indicate a lack of information for many indicators in majority of Member States Lack of data presents an opportunity to call for improving data collection and monitoring systems in Member States

Thank you for your attention mollerl@who.int scholinlis@who.int brummerj@who.int